Nina Bhardwaj, MD, PhD
- PROFESSOR | Medicine, Hematology and Medical Oncology
- PROFESSOR | Urology
Research Topics:AIDS/HIV, Immunology
Nina Bhardwaj MD, PhD, is Professor of Medicine (Hematology and Medical Oncology) and Urology. She is the Director of Immunotherapy, Medical Director of the Vaccine and Cell Therapy Laboratory, and Co-Director of the Cancer Immunology Program at The Tisch Cancer Institute. She is a faculty member of the Icahn Genomics Institute. Dr. Bhardwaj holds the Ward Coleman Chair in Cancer Research.
Dr. Bhardwaj has made seminal contributions to human dendritic cell biology, specifically with respect to their isolation, subset discovery, immunobiology, antigen presenting function, and use of vaccine adjuvants in humans. She developed Toll Like Receptor agonist- and dendritic cell-based vaccines for the treatment of both cancer and infection in several investigator-initiated studies and has pioneered neoantigen vaccine studies at The Tisch Cancer Institute. Dr. Bhardwaj translates basic science advancements into clinically relevant patient trials.
Dr. Bhardwaj was named one of the Scientific American’s Top 50 Researchers, receiving the Award for Medical Research in 2004. She received the Fred W. Alt Award for new discoveries in Immunology in 2015 from the Cancer Research Institute. Dr. Bhardwaj is a senior editor for Cancer Immunology Research and Frontiers in Immunology. She has served on numerous NIH Study Sections and advisory councils, and was formerly chair of the Cancer Immunology Steering Committee of the American Association for Cancer Research. Dr. Bhardwaj has successfully secured multiple federal and foundation grants and has authored more than 200 publications.
For more information, visit our laboratory page at http://icahn.mssm.edu/research/labs/bhardwaj-laboratory
Dr. Bhardwaj is on Twitter at @BhardwajLab
Multi-Disciplinary Training AreaImmunology [IMM]
MD, New York University School of Medicine
PhD, New York University School of Medicine
Internship, Brigham and Womens Hospital, Harvard Medical School,
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Bhardwaj during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.
- MD Anderson Cancer Center; weill Cornell University Medical center
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- Dana Farber Cancer Center; India Alliance, Team Science Grant; Linkoping University; Oncovir, Inc.; Stand Up To Cancer (SU2C) ; weill Cornell University Medical center
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.